Campaigners in Northern Ireland have called for the introduction of a 'game-changing' drug that will prevent HIV. On Friday ...

MSD’s investigational two-drug HIV combination has been proven safe, efficacious and non-inferior to current standard of care ...

Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 ...

The UK has approved a long-acting HIV jab that requires just one injection every two months. Doctors call it a breakthrough ...

The shot, given six times a year or every other month, is an alternative to taking daily pills to protect against ever ...

New EACS 2025 data show once-weekly islatravir and lenacapavir maintain HIV viral suppression for 96 weeks with no resistance ...

The HIV-prevention pill PrEP will now be covered under most insurance plans. Its name is short for pre-exposure prophylaxis. Supporters of the move to make it free to those who are insured call it a ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...

The UK's drugs cost-effectiveness watchdog has given a positive recommendation for ViiV Healthcare's HIV drug, enabling ...

KZN to receive Lenacapavir,new long-acting HIV prevention injection. Minister Motsoaledi confirms rollout to 360 clinics, for ...

NICE has recommended cabotegravir, the UK’s first long-acting injectable HIV prevention drug, expanding access for people unable to take daily tablets.

England’s drug pricing regulator recommended GSK Plc’s HIV prevention injection, making it the first long-acting pre-exposure ...